Previous close | 6.00 |
Open | 6.00 |
Bid | 2.60 |
Ask | 4.90 |
Strike | 10.00 |
Expiry date | 2024-10-18 |
Day's range | 6.00 - 6.00 |
Contract range | N/A |
Volume | |
Open interest | 26 |
Rorema Beheer disclosed a large position in healthcare IT solutions firm TruBridge. PL Capital Advisors increased its stake in regional bank Evans Bancorp.
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company granted stock options to four new employees to purchase an aggregate of 51,600 shares of the Company's common stock, effective as of June 3, 2024. These awards were approved by the Compensation Comm
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that its management team will participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Wednesday, June 5, 2024, at 2:00 p.m. ET Location: Marriott Marquis in New York, NY